论文部分内容阅读
NanoMaterials Technology Private Limited (NMT) of Singapore announced on April8th, 2010 that it has signed an exclusive licensing agreement with Beijing WinsunnyPharmaceutical Company Limited (BWP) for the use of its proprietary High GravityControlled Precipitation (HGCP) Technology to manufacture, market and distribute ageneric version of a worldwide blockbuster hyperlipidemiacontrolling drug in China witha potential market size of over US$900 million. Currently, there are 90 million patients in
NanoMaterials Technology Private Limited (NMT) of Singapore announced on April8th, 2010 that it has signed an exclusive licensing agreement with Beijing Winsunny Pharmaceutical Company Limited (BWP) for the use of its proprietary High Gravity Controlled Precipitation (HGCP) Technology to manufacture, market and distribute ageneric version of a worldwide blockbuster hyperlipidemiacontrolling drug in China witha potential market size of over US $ 900 million. Currently, there are 90 million patients in